Showing results (91-100 of 113) with videos related to

Sort By:
Pageof 12
The Korean Journal of Hepatology|September 28, 2007
[Efficacy of transarterial chemolipiodolization with or without 3-dimensional conformal radiotherapy for huge HCC with portal vein tumor thrombosis]Chan Ran You, Jeong Won Jang, Seok Hui Kang, et al.
Frontiers in Oncology|December 17, 2020
Diffusion-Weighted Magnetic Resonance Imaging in Hepatocellular Carcinoma as a Predictor of a Response to Cisplatin-Based Hepatic Arterial Infusion ChemotherapyPil Soo Sung, Moon Hyung Choi, Hyun Yang, et al.
Abdominal Radiology (New York)|April 28, 2024
Higher objective responses by hepatic arterial infusion chemotherapy following atezolizumab and bevacizumab failure than when used as initial therapy in hepatocellular carcinoma: a retrospective studyJae-Sung Yoo, Ji Hoon Kim, Hee Sun Cho, et al.
World Journal of Gastroenterology|August 8, 2013
Hepatic arterial infusion chemotherapy in hepatocellular carcinoma with portal vein tumor thrombosisDo Seon Song, Si Hyun Bae, Myeong Jun Song, et al.
European Journal of Nuclear Medicine and Molecular Imaging|February 26, 2013
18F-fluorodeoxyglucose PET/CT predicts tumour progression after transarterial chemoembolization in hepatocellular carcinomaMyeong Jun Song, Si Hyun Bae, Sung Won Lee, et al.
Transplantation|June 30, 2022
Long-term Clinical Outcomes and Predictive Factors for Living-donor Liver Transplant Recipients With Biliary StricturesJi Won Han, Jong Young Choi, Soon Kyu Lee, et al.
Journal of Hepatology|July 25, 2012
Comparative study between doxorubicin-eluting beads and conventional transarterial chemoembolization for treatment of hepatocellular carcinomaMyeong Jun Song, Ho Jong Chun, Do Seon Song, et al.
Cancer Research and Treatment|July 21, 2014
A case-control study to identify risk factors for totally implantable central venous port-related bloodstream infectionGuk Jin Lee, Sook Hee Hong, Sang Young Roh, et al.
Frontiers in Oncology|December 27, 2024
Improved survival with second-line hepatic arterial infusion chemotherapy after atezolizumab-bevacizumab failure in hepatocellular carcinomaJi Yeon Lee, Jaejun Lee, Suho Kim, et al.
Cureus|March 18, 2024
Role of Portosystemic Shunt and Portal Vein Stent in Managing Portal Hypertension Due to Hematological DiseasesJi Hoon Kim, Suho Kim, Hee-Chul Nam, et al.
Pageof 12